SQSTM1 and Paget?s Disease of Bone
The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Mutations in the Sequestosome 1 gene ( SQSTM1; also known as p62) have recently been identified as the cause of 5q35-linked Paget's disease of bone (PDB). All of the mutations identified to date affect the ubiquitin-associated (UBA) domain of SQSTM1, a region of the protein that binds noncovalently to ubiquitin. In this review we consider the possible functional significance of the SQSTM1-ubiquitin interaction, and consequences of the SQSTM1 UBA domain mutations. Clarification of the in vivo roles of SQSTM1 in bone-cell function will be central to improving our understanding of the molecular pathogenesis of PDB and related conditions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most recently, mutations in the sequestosome 1 gene, a scaffold protein in the NF-B signaling pathway, have been demonstrated in some cases of familial and sporadic PDB (399 -404).”
From Receptor Activator of Nuclear Factor κB Ligand and Osteoprotegerin Regulation of Bone Remodeling in Health and Disease (2008) · cites this paper as [404]
Citations
Cites
Hershko, A., & Ciechanover, A. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.425 · Cited by 8,840
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599 · cited 1×
“Consistent with these observations, the UBA domain of SQSTM1 [76, 77] is reported to mediate interaction with both multi-ubiquitin chains [51, 78] and monomeric ubiquitin [79].”
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125 · cited 2×
“upon receptor stimulation [67, 68], is consistent with a model in which the UBA domain of SQSTM1 mediates recruitment of the protein along with aPKCs to signaling complexes via binding to the TRAF6 ubiquitin chain.”
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
Recognition of the polyubiquitin proteolytic signal
Thrower, J. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.1.94 · Cited by 1,716 · cited 1×
“The SQSTM1 protein, via its UBA domain, is able to bind K48-linked multi-ubiquitin chains [51, 78] which, as noted previously, are proteasomal degradation signals when attached to substrate proteins [64].”
Genetic regulation of osteoclast development and function
Teitelbaum, S. L., & Ross, F. P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1122 · Cited by 1,701
PEST sequences and regulation by proteolysis
Rechsteiner, M., & Rogers, S. W. (1996) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(96)10031-1 · Cited by 1,640 · cited 1×
“PEST sequences occur in proteins that are targets of ubiquitindependent proteolysis (see subsequent text) [56], and cell stress associated with arsenite or arsenate is reported to lead to the accumulation of ubiquitylated forms of SQSTM1 in cultured osteoblasts [57].”
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · cited 1×
“Significantly, RANK is a member of the TNF receptor family [41] that directly interacts with and requires TRAF6 for activation of NFjB signaling [42], and TRAF6-deficient mice lack osteoclasts or show defective osteoclast function [43, 44].”
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595 · cited 1×
“inclusions appear to be neuroprotective [87, 88].”
A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
Chau, V., Tobias, J. W., Bachmair, A., Marriott, D., Ecker, D. J., Gonda, D. K., & Varshavsky, A. (1989) · Science · doi:10.1126/science.2538923 · Cited by 1,535
Research works printed but not linked: 6
- AG Huvos, 1986, A clinicopathologic analysis of 117 patients older than 60 years. Cancer, 57, 1442
- MFA Montagu, 1949, Am J Hum Genet, 1, 94
- K Shafheutle, 1997, Bone, 20, O017
- DA Good, 2002, Single base-pair deletion of gene encoding Sequestosome 1 (SQSTM1/p62) in Paget?s disease of bone. [abstract 04:13]. ANZBMS 12th Annual Scientific Meeting
- K Hofmann, 1996, Trends Biochem Sci, 21, 172, 10.1016/S0968-0004(96)30015-7 · doi:10.1016/s0968-0004(96)30015-7 · Paper page
- K Hofmann, 1996, Trends Biochem Sci, 21, 172, 10.1016/S0968-0004(96)30015-7 · doi:10.1016/s0968-0004(96)30015-7 · Paper page
Cited by
Kearns, A. E., Khosla, S., & Kostenuik, P. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0014 · Cited by 824
CYLD: a tumor suppressor deubiquitinase regulating NF-κB activation and diverse biological processes
Sun, S.-C. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.43 · Cited by 400
“Deregulated osteoclast activity is the major cause of bone erosion in osteolytic diseases, such as osteoporosis, rheumatoid arthritis, and Paget’s disease of bone.(74,75) The development of osteoclasts is driven by signal transduction mediated by a TNFR family member, RANK.”
BackgroundPathogenesis and management of Paget's disease of bone
Ralston, S. H., Langston, A. L., & Reid, I. R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61035-1 · Cited by 260
Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice
Jin, W., Chang, M., Paul, E. M., Babu, G., Lee, A. J., Reiley, W., Wright, A., Zhang, M., You, J., & Sun, S.-C. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34257 · Cited by 195
“Such genetic alterations of p62 are etiologically associated with development of Paget disease of bone (PDB), a severe bone disorder characterized by formation of giant OCs, excessive bone resorption, and irregular bone formation (15, 19, 20).”
BackgroundKimonis, V. E., Mehta, S. G., Fulchiero, E. C., Thomasova, D., Pasquali, M., Boycott, K., Neilan, E. G., Kartashov, A., Forman, M. S., Tucker, S., et al. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31862 · Cited by 175
Metadata
- Authors
- Layfield, R., & Hocking, L. J.
- Affiliations
- University of Nottingham (GB)
- University of Aberdeen (GB)
- Corresponding author
- Layfield, R.
- Venue
- Calcified Tissue International
- Published
- 2004-09-16
- Volume
- 75
- Issue
- 5
- Pages
- 347-357
- ISSN
- 0171-967X (ISSN-L)
- 1432-0827
- OpenAlex
- W2045763473
- Cited by
- 76
- References
- 100
- Citations by year
- 2026: 2 · 2025: 1 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 5 · 2013: 2 · 2012: 6
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Calcified Tissue International (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Alkaline Phosphatase Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- p62, Paget's disease of bone, UBA domain, ubiquitin binding, bone cell function, molecular pathogenesis, genetic mutations
- MeSH terms
- DNA Mutational Analysis, Humans, Models, Biological, Models, Molecular, Mutation, Osteitis Deformans, Proteins, Protein Structure, Tertiary, Ubiquitin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SQSTM1 and Paget?s Disease of Bone. https://app.cochat.ai/papers/10.1007/s00223-004-0041-0
- The paper
- Layfield, R., & Hocking, L. J. (2004). SQSTM1 and Paget?s Disease of Bone. Calcified Tissue International. https://doi.org/10.1007/s00223-004-0041-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.